Peter Savas

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 15

Top Topics

Metastatic Breast Cancer

Top Venues

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Science signaling

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Schmid, Nicholas C Turner, Carlos Henrique Barrios, Steven Jay Isakoff, Sung-Bae Kim, Marie-Paule Sablin, Shigehira Saji, Peter Savas, Gregory A Vidal, Mafalda Oliveira, Joyce O'Shaughnessy, Antoine Italiano, Enrique Espinosa, Valentina Boni, Shane White, Beatriz Rojas, Rui Gilberto Ferreira, Yee Soo Chae, Igor Bondarenko, Jieun Lee, Cesar Torres Mattos, Jorge Luis Martinez Rodriguez, Lisa H Lam, Surai Jones, Sarah-Jayne Reilly, Xiayu Huang, Kalpit Shah, Rebecca A Dent
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Zhi Ling Teo, Lenka Oplustil O'Connor, Stephanie Versaci, Kylie A Clarke, Emmaline R Brown, Luke W Percy, Keilly Kuykhoven, Christopher P Mintoff, Peter Savas, Balaji Virassamy, Stephen J Luen, Ann Byrne, Sneha Sant, Geoffrey J Lindeman, Phillip K Darcy, Sherene Loi
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer. NPJ breast cancer 9 (1) (2023)
Peter Savas, Louisa L Lo, Stephen J Luen, Elizabeth F Blackley, Jason Callahan, Kate Moodie, Courtney T van Geelen, Yi-An Ko, Chen-Fang Weng, Lironne Wein, Maria João Silva, Andjelija Zivanovic Bujak, Miriam M Yeung, Sarah Ftouni, Rodney John Hicks, Prudence A Francis, Chee Khoon Lee, Sarah-Jane Dawson, Sherene Loi
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II Study. Cancer discovery 12 (9) (2022)
Jennifer Mooi, Fiona Chionh, Peter Savas, Jessica Da Gama Duarte, Geoffrey Chong, Stephen Brown, Rachel Wong, Timothy J Price, Alysson Wann, Effie Skrinos, John M Mariadason, Niall C Tebbutt
Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
Sunit Sarkar, Ben Tran, Lisa G Horvath, Michael Lam, Peter Savas, Peter S Grimison, James R Whittle, James C Kuo, Nicole Signal, David Edmonds, Philip J Hogg, Danny Rischin, Jayesh Desai, Anne Hamilton
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours. Cancer chemotherapy and pharmacology 87 (5) (2021)
Peter Savas, Roberto Salgado, Sherene Loi
Seeing the forest and the tree: TILs and PD-L1 as immune biomarkers. Breast cancer research and treatment 189 (3) (2021)
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon, Ashish Sharma, Jennifer K Kerner, Carsten Denkert, Yinyin Yuan, Khalid AbdulJabbar, Stephan Wienert, Peter Savas, Leonie Voorwerk, Andrew H Beck, Anant Madabhushi, Johan Hartman, Manu M Sebastian, Hugo M Horlings, Jan Hudeček, Francesco Ciompi, David A Moore, Rajendra Singh, Elvire Roblin, Marcelo Luiz Balancin, Marie-Christine Mathieu, Jochen K Lennerz, Pawan Kirtani, I-Chun Chen, Jeremy P Braybrooke, Giancarlo Pruneri, Sandra Demaria, Sylvia Adams, Stuart J Schnitt, Sunil R Lakhani, Federico Rojo, Laura Comerma, Sunil S Badve, Mehrnoush Khojasteh, William Fraser Symmans, Christos Sotiriou, Paula I Gonzalez Ericsson, Katherine L Pogue-Geile, Rim S Kim, David L Rimm, Giuseppe Viale, Stephen M Hewitt, John M S Bartlett, Frédérique Penault-Llorca, Shom Goel, Huang-Chun Lien, Sibylle Loibl, Zuzana Kos, Sherene Loi, Matthew G Hanna, Stefan Michiels, Marleen Kok, Torsten O Nielsen, Alexander J F Lazar, Zsuzsanna Bago-Horvath, Loes F S Kooreman, Jeroen van der Laak, Joel Saltz, Brandon D Gallas, Uday Kurkure, Michael Barnes, Roberto Salgado, Lee A D Cooper, null null
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group. NPJ breast cancer 6 (2020)
Ann Byrne, Peter Savas, Sneha Sant, Ran Li, Balaji Virassamy, Stephen J Luen, Paul A Beavis, Laura K Mackay, Paul J Neeson, Sherene Loi
Tissue-resident memory T cells in breast cancer control and immunotherapy responses. Nature reviews. Clinical oncology 17 (6) (2020)
Zuzana Kos, Elvire Roblin, Rim S Kim, Stefan Michiels, Brandon D Gallas, Weijie Chen, Koen K van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O Nielsen, Sunil S Badve, William Fraser Symmans, Christos Sotiriou, David L Rimm, Stephen Hewitt, Carsten Denkert, Sibylle Loibl, Stephen J Luen, John M S Bartlett, Peter Savas, Giancarlo Pruneri, Deborah A Dillon, Maggie Chon U Cheang, Andrew Tutt, Jacqueline A Hall, Marleen Kok, Hugo Mark Horlings, Anant Madabhushi, Jeroen van der Laak, Francesco Ciompi, Anne-Vibeke Laenkholm, Enrique Bellolio, Tina Gruosso, Stephen B Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H Beck, Jen Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin Hiley, Maise Al Bakir, Alexander J F Lazar, Stephen Naber, Stephan Wienert, Miluska Castillo, Curigliano Giuseppe, Maria-Vittoria Dieci, Fabrice André, Charles Swanton, Jorge Reis-Filho, Joseph A Sparano, Eva Balslev, I-Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine Pogue-Geile, Kim R M Blenman, Frédérique Penault-Llorca, Stuart Schnitt, Sunil R Lakhani, Anne Vincent-Salomon, Federico Rojo, Jeremy P Braybrooke, Matthew G Hanna, M Teresa Soler-Monsó, Daniel Bethmann, Carlos A Castaneda, Karen Willard-Gallo, Ashish Sharma, Huang-Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I Gonzalez Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee A D Cooper, Mohamed Amgad, David A Moore, Roberto Salgado, null null
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ breast cancer 6 (2020)
Thomas B K Watkins, Emilia L Lim, Marina Petkovic, Sergi Elizalde, Nicolai Juul Birkbak, Gareth A Wilson, David A Moore, Eva Grönroos, Andrew Rowan, Sally M Dewhurst, Jonas Demeulemeester, Stefan C Dentro, Stuart Horswell, Lewis Au, Kerstin Haase, Mickael Escudero, Rachel Rosenthal, Maise Al Bakir, Hang Xu, Kevin Litchfield, Wei-Ting Lu, Thanos P Mourikis, Michelle Dietzen, Lavinia Spain, George D Cresswell, Dhruva Biswas, Philippe Lamy, Iver Nordentoft, Katja Harbst, Francesc Castro Giner, Lucy R Yates, Franco Caramia, Fanny Jaulin, Cécile Vicier, Ian P M Tomlinson, Priscilla K Brastianos, Raymond J Cho, Boris C Bastian, Lars Dyrskjøt, Göran B Jönsson, Peter Savas, Sherene Loi, Peter J Campbell, Fabrice Andre, Nicholas M Luscombe, Neeltje Steeghs, Vivianne C G Tjan-Heijnen, Zoltan Szallasi, Samra Turajlic, Mariam Jamal-Hanjani, Peter Van Loo, Samuel F Bakhoum, Roland F Schwarz, Nicholas McGranahan, Charles Swanton
Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587 (7832) (2020)
Peter Savas, Sherene Loi
Metastatic Breast Cancer: TIL it is Too Late. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Emma Nolan, Peter Savas, Antonia N Policheni, Phillip K Darcy, François Vaillant, Christopher P Mintoff, Sathana Dushyanthen, Mariam Mansour, Jia-Min B Pang, Stephen B Fox, null null, Charles M Perou, Jane E Visvader, Daniel H D Gray, Sherene Loi, Geoffrey J Lindeman
Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer. Science translational medicine 9 (393) (2018)
Emiliano Cocco, F Javier Carmona, Pedram Razavi, Helen H Won, Yanyan Cai, Valentina Rossi, Carmen Chan, James Cownie, Joanne Soong, Eneda Toska, Sophie G Shifman, Ivana Sarotto, Peter Savas, Michael J Wick, Kyriakos P Papadopoulos, Alyssa Moriarty, Richard E Cutler, Francesca Avogadri-Connors, Alshad S Lalani, Richard P Bryce, Sarat Chandarlapaty, David M Hyman, David B Solit, Valentina Boni, Sherene Loi, Jose Baselga, Michael F Berger, Filippo Montemurro, Maurizio Scaltriti
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). Science signaling 11 (551) (2018)
Peter Savas, Balaji Virassamy, Chengzhong Ye, Agus Salim, Christopher P Mintoff, Franco Caramia, Roberto Salgado, David J Byrne, Zhi L Teo, Sathana Dushyanthen, Ann Byrne, Lironne Wein, Stephen J Luen, Catherine Poliness, Sophie S Nightingale, Anita S Skandarajah, David E Gyorki, Chantel M Thornton, Paul A Beavis, Stephen B Fox, null null, Phillip K Darcy, Terence P Speed, Laura K Mackay, Paul J Neeson, Sherene Loi
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nature medicine 24 (7) (2018)
Peter Savas, Zhi Ling Teo, Christophe M Lefèvre, Christoffer Flensburg, Franco Caramia, Kathryn Alsop, Mariam Mansour, Prudence A Francis, Heather A Thorne, Maria Joao Silva, Nnennaya Kanu, Michelle Dietzen, Andrew Rowan, Maik Kschischo, Stephen B Fox, David D Bowtell, Sarah-Jane Dawson, Terence P Speed, Charles Swanton, Sherene Loi
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". PLoS medicine 13 (12) (2016)